{
    "hands_on_practices": [
        {
            "introduction": "A cornerstone of preoperative evaluation is the ability to rapidly synthesize a patient's overall physiological status into a standardized risk category. The American Society of Anesthesiologists (ASA) Physical Status classification system provides this essential framework, allowing clinicians to communicate a patient's baseline health concisely. This exercise  will hone your ability to apply the ASA criteria across a spectrum of patient complexities, a fundamental skill for gauging perioperative risk and planning appropriate care.",
            "id": "4660009",
            "problem": "A surgeon must assign and justify the American Society of Anesthesiologists (ASA) Physical Status classification for three patients as part of preoperative patient evaluation and optimization. The ASA Physical Status system categorizes risk based on the presence and severity of systemic disease and its impact on functional capacity and physiologic stability. Use the core definitions of ASA Physical Status categories as the fundamental base: absence of systemic disease versus mild systemic disease without substantive functional limitation, severe systemic disease with substantive functional limitation, and severe systemic disease that is a constant threat to life. Your task is to determine the ASA class for each patient grounded in those definitions and to note key perioperative implications that follow from your classification, including optimization needs, monitoring intensity, and whether emergency status modifies risk.\n\nVignette $1$: A $52$-year-old woman is scheduled for elective laparoscopic cholecystectomy. She has well-controlled hypertension (HTN) on a single angiotensin receptor blocker, type $2$ diabetes mellitus (DM) with glycated hemoglobin (HbA1c) $6.8\\%$, and body mass index (BMI) $32$ $\\mathrm{kg/m^2}$. She is a non-smoker, walks briskly daily, and can climb $2$ flights of stairs without limitation, consistent with more than $7$ Metabolic Equivalent of Task (METs). She has no known coronary artery disease (CAD), heart failure, chronic kidney disease (CKD), or chronic obstructive pulmonary disease (COPD). Physical examination and basic laboratory work are within normal limits.\n\nVignette $2$: A $68$-year-old man is scheduled for elective right hemicolectomy for colon adenocarcinoma. Comorbidities include ischemic cardiomyopathy with left ventricular ejection fraction (EF) $35\\%$ and New York Heart Association (NYHA) class II symptoms, prior myocardial infarction (MI) $2$ years ago, CKD stage $3$ with estimated glomerular filtration rate (eGFR) $45$ $\\mathrm{mL/min/1.73\\,m^2}$, and moderate COPD with forced expiratory volume in $1$ second ($\\mathrm{FEV}_{1}$) $55\\%$ predicted, controlled on long-acting bronchodilators. He also has obstructive sleep apnea (OSA) adherent to continuous positive airway pressure (CPAP). He can perform light housework but becomes dyspneic with moderate exertion, approximating $4$ METs. He has no active angina, no decompensated heart failure, and his oxygen saturation is $95\\%$ on room air.\n\nVignette $3$: A $74$-year-old woman presents with acute small-bowel obstruction due to a strangulating ventral hernia and is scheduled for urgent open exploration. She has decompensated congestive heart failure (CHF) with EF $20\\%$, orthopnea, and paroxysmal nocturnal dyspnea; recent episodes of chest pain at rest concerning for unstable angina; oxygen-dependent COPD with baseline partial pressure of carbon dioxide (PaCO$_2$) $56$ $\\mathrm{mmHg}$; and acute kidney injury with serum creatinine $3.2$ $\\mathrm{mg/dL}$ rising from baseline $1.1$ $\\mathrm{mg/dL}$ in the last $48$ hours. She is hemodynamically stable on admission without vasopressors, but her conditions remain tenuous. The case is urgent rather than elective, and by ASA convention would carry the emergency suffix ($E$) when applicable.\n\nWhich option correctly lists the ASA Physical Status class for Patient $1$, Patient $2$, and Patient $3$ respectively?\n\nA. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nB. Patient $1$: ASA $1$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nC. Patient $1$: ASA $2$; Patient $2$: ASA $4$; Patient $3$: ASA $4$\n\nD. Patient $1$: ASA $3$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nE. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $5$",
            "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n\nThe problem provides the following data and definitions for the American Society of Anesthesiologists (ASA) Physical Status classification system:\n*   **Core Definitions:**\n    *   Absence of systemic disease.\n    *   Mild systemic disease without substantive functional limitation.\n    *   Severe systemic disease with substantive functional limitation.\n    *   Severe systemic disease that is a constant threat to life.\n*   **Vignette $1$:** A $52$-year-old woman for elective laparoscopic cholecystectomy.\n    *   Comorbidities: Well-controlled hypertension ($\\mathrm{HTN}$) on one angiotensin receptor blocker, type $2$ diabetes mellitus ($\\mathrm{DM}$) with glycated hemoglobin ($\\mathrm{HbA1c}$) $6.8\\%$, body mass index ($\\mathrm{BMI}$) $32$ $\\mathrm{kg/m^2}$.\n    *   Negative History: Non-smoker, no known coronary artery disease ($\\mathrm{CAD}$), heart failure ($\\mathrm{HF}$), chronic kidney disease ($\\mathrm{CKD}$), or chronic obstructive pulmonary disease ($\\mathrm{COPD}$).\n    *   Functional Status: Excellent, can climb $2$ flights of stairs without limitation, equivalent to more than $7$ Metabolic Equivalent of Task ($\\mathrm{METs}$).\n    *   Examination: Physical exam and basic labs are within normal limits.\n*   **Vignette $2$:** A $68$-year-old man for elective right hemicolectomy.\n    *   Comorbidities: Ischemic cardiomyopathy with left ventricular ejection fraction ($\\mathrm{EF}$) $35\\%$, New York Heart Association ($\\mathrm{NYHA}$) class $\\mathrm{II}$ symptoms, prior myocardial infarction ($\\mathrm{MI}$) $2$ years ago, $\\mathrm{CKD}$ stage $3$ with estimated glomerular filtration rate ($\\mathrm{eGFR}$) $45$ $\\mathrm{mL/min/1.73\\,m^2}$, moderate $\\mathrm{COPD}$ with forced expiratory volume in $1$ second ($\\mathrm{FEV}_{1}$) $55\\%$ predicted, obstructive sleep apnea ($\\mathrm{OSA}$) adherent to continuous positive airway pressure ($\\mathrm{CPAP}$).\n    *   Functional Status: Limited, can perform light housework but becomes dyspneic with moderate exertion, approximating $4$ $\\mathrm{METs}$.\n    *   Current Status: Stable, no active angina, no decompensated heart failure, oxygen saturation $95\\%$ on room air.\n*   **Vignette $3$:** A $74$-year-old woman for urgent open exploration of a strangulating ventral hernia.\n    *   Comorbidities: Decompensated congestive heart failure ($\\mathrm{CHF}$) with $\\mathrm{EF}$ $20\\%$, orthopnea, and paroxysmal nocturnal dyspnea; recent chest pain at rest concerning for unstable angina; oxygen-dependent $\\mathrm{COPD}$ with baseline partial pressure of carbon dioxide ($\\mathrm{PaCO}_2$) $56$ $\\mathrm{mmHg}$; acute kidney injury with serum creatinine $3.2$ $\\mathrm{mg/dL}$ (baseline $1.1$ $\\mathrm{mg/dL}$).\n    *   Current Status: Tenuous but hemodynamically stable on admission without vasopressors.\n    *   Urgency: Urgent, designated with an 'E' suffix.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem is scientifically grounded, utilizing the standard and widely accepted ASA Physical Status classification system. The patient vignettes are medically plausible and contain objective, quantifiable data (e.g., $\\mathrm{HbA1c}$, $\\mathrm{EF}$, $\\mathrm{eGFR}$, $\\mathrm{FEV}_{1}$) consistent with real-world clinical scenarios. The provided definitions, while simplified, correspond accurately to the core concepts of ASA classes $1$ through $4$. The problem is self-contained, with each vignette providing sufficient information to perform the classification. There are no contradictions, ambiguities, or violations of scientific principles. The problem is well-posed and objective.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. A solution will be derived by applying the provided definitions to each patient vignette.\n\n### Derivation of Solution\n\nThe ASA Physical Status classification is determined for each patient based on the severity of their systemic diseases and the resulting functional limitations, as per the provided framework.\n\n**Patient 1 Analysis:**\n*   This $52$-year-old woman has multiple systemic diseases: hypertension ($\\mathrm{HTN}$), type $2$ diabetes mellitus ($\\mathrm{DM}$), and Class I obesity ($\\mathrm{BMI} = 32$ $\\mathrm{kg/m^2}$). This definitively excludes ASA class $1$ (\"absence of systemic disease\").\n*   However, her diseases are characterized as \"well-controlled\" (single medication for $\\mathrm{HTN}$, $\\mathrm{HbA1c}$ of $6.8\\%$) and, critically, they do not impose any \"substantive functional limitation.\" Her excellent functional capacity of greater than $7$ $\\mathrm{METs}$ confirms this.\n*   This clinical picture perfectly matches the definition of \"mild systemic disease without substantive functional limitation.\"\n*   Therefore, Patient $1$ is classified as **ASA $2$**.\n\n**Patient 2 Analysis:**\n*   This $68$-year-old man presents with multiple, severe chronic conditions affecting several major organ systems.\n*   Cardiac: Ischemic cardiomyopathy with a moderately reduced ejection fraction ($\\mathrm{EF}$ $35\\%$) and symptomatic heart failure ($\\mathrm{NYHA}$ class $\\mathrm{II}$). A history of $\\mathrm{MI}$ more than $3$ months prior ($2$ years ago) with these sequelae is a significant factor.\n*   Renal: Chronic kidney disease stage $3$ with an $\\mathrm{eGFR}$ of $45$ $\\mathrm{mL/min/1.73\\,m^2}$ represents a moderate impairment.\n*   Pulmonary: Moderate $\\mathrm{COPD}$ ($\\mathrm{FEV}_{1}$ $55\\%$ predicted) requiring long-acting bronchodilators.\n*   These conditions result in a \"substantive functional limitation,\" as evidenced by his poor exercise tolerance of approximately $4$ $\\mathrm{METs}$.\n*   This scenario corresponds directly to the definition of \"severe systemic disease with substantive functional limitation.\" The diseases are chronic and described as currently stable (\"no active angina, no decompensated heart failure\"), not an immediate threat to life.\n*   Therefore, Patient $2$ is classified as **ASA $3$**.\n\n**Patient 3 Analysis:**\n*   This $74$-year-old woman is acutely ill with multiple life-threatening conditions.\n*   Cardiac: She has decompensated heart failure with a severely reduced ejection fraction ($\\mathrm{EF}$ $20\\%$) and active symptoms (orthopnea, $\\mathrm{PND}$). Furthermore, she has symptoms suggestive of unstable angina.\n*   Pulmonary: She has end-stage, oxygen-dependent $\\mathrm{COPD}$ with chronic respiratory failure (hypercarbia with $\\mathrm{PaCO}_2$ $56$ $\\mathrm{mmHg}$).\n*   Renal: She has acute-on-chronic kidney failure.\n*   These conditions are severe, unstable, and actively decompensated. Collectively, they represent a \"constant threat to life,\" independent of the surgical problem. The patient's condition is tenuous despite being hemodynamically stable without vasopressors on admission. This clinical state fits the definition for ASA class $4$.\n*   She is not yet \"moribund\" (ASA $5$), a state implying imminent demise, often associated with profound shock or multi-organ failure unresponsive to therapy. The fact that she is stable without vasopressors upon admission argues for ASA $4$ over ASA $5$. The urgent nature of her surgery would add an 'E' modifier to her classification, making it ASA $4$E. The question asks for the numerical class.\n*   Therefore, Patient $3$ is classified as **ASA $4$**.\n\n**Summary of Classifications:**\n*   Patient $1$: ASA $2$\n*   Patient $2$: ASA $3$\n*   Patient $3$: ASA $4$\n\n### Option-by-Option Analysis\n\n*   **A. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option matches the derived classifications for all three patients. Patient $1$ has mild, controlled disease without functional limitation. Patient $2$ has severe, chronic disease with significant functional limitation. Patient $3$ has severe, decompensated disease that is a constant threat to life.\n    **Verdict: Correct.**\n\n*   **B. Patient $1$: ASA $1$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $1$ as ASA $1$. An ASA $1$ patient is normal and healthy, which is incorrect for a patient with hypertension, diabetes, and obesity.\n    **Verdict: Incorrect.**\n\n*   **C. Patient $1$: ASA $2$; Patient $2$: ASA $4$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $2$ as ASA $4$. While his diseases are severe, they are chronic and described as stable. They cause functional limitation (characteristic of ASA $3$) but are not an immediate, constant threat to life (characteristic of ASA $4$).\n    **Verdict: Incorrect.**\n\n*   **D. Patient $1$: ASA $3$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $1$ as ASA $3$. ASA $3$ implies severe disease with substantive functional limitation. This patient has excellent functional capacity (>$7$ METs), which is inconsistent with an ASA $3$ classification.\n    **Verdict: Incorrect.**\n\n*   **E. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $5$**\n    This option incorrectly classifies Patient $3$ as ASA $5$. ASA $5$ denotes a moribund patient not expected to survive without the operation. The patient's hemodynamic stability on admission without vasopressors, though tenuous, makes ASA $4$ (a constant threat to life) a more precise classification than ASA $5$.\n    **Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Beyond the general assessment provided by the ASA score, effective preoperative optimization often requires a more granular, quantitative estimate of organ-specific risk. For cardiac complications, the Revised Cardiac Risk Index (RCRI) is a powerful and widely validated tool. This practice problem  challenges you to move from qualitative assessment to quantitative prediction by calculating the RCRI score and interpreting its implications for a patient's management, a critical step in evidence-based perioperative decision-making.",
            "id": "4659946",
            "problem": "A $70$-year-old man is scheduled for an elective open sigmoid colectomy for complicated diverticulitis, which is an intraperitoneal operation. His past medical history includes type $2$ diabetes mellitus treated with basal-bolus insulin, a prior ischemic cerebrovascular accident with mild residual hemiparesis, and chronic kidney disease with a most recent preoperative serum creatinine of $2.1$ mg/dL. He denies chest pain and orthopnea, has no known ischemic heart disease and no history of congestive heart failure. He can perform light housework but cannot climb one flight of stairs without stopping, consistent with functional capacity of $<4$ metabolic equivalents (METs). There are no active cardiac conditions identified on history, examination, or electrocardiogram.\n\nUsing only well-tested perioperative risk stratification facts and definitions, identify the qualifying elements for the Revised Cardiac Risk Index (RCRI), compute the total RCRI score, and then map this score to the estimated probability of a major adverse cardiac event (MACE) according to the original risk categories of the index. Express the final probability as a pure decimal number without a percent sign, and round your answer to three significant figures.\n\nBased on this computed risk, apply the standard decision framework from professional society perioperative guidelines for general surgery to determine whether further noninvasive cardiac testing would be warranted; justify the decision qualitatively in your reasoning. Your final submitted answer must be only the computed MACE probability as specified above.",
            "solution": "The problem requires a three-part analysis based on a provided clinical vignette: first, a quantitative risk stratification using the Revised Cardiac Risk Index (RCRI); second, mapping this risk score to a probability of a major adverse cardiac event (MACE); and third, a qualitative application of clinical guidelines to decide on further preoperative testing. The final answer is to be the computed MACE probability.\n\nThe validation of the problem statement confirms that it is scientifically grounded, well-posed, and objective. It provides a realistic clinical scenario with all necessary data points to apply the specified risk assessment tool. The problem is valid.\n\nThe solution proceeds by first identifying the six independent predictors of major cardiac complications as defined by the RCRI (Lee et al., 1999). Each point in the index corresponds to one of these predictors.\n\nThe six criteria for the Revised Cardiac Risk Index are:\n1.  High-risk surgery: Intraperitoneal, intrathoracic, or suprainguinal vascular surgery.\n2.  History of ischemic heart disease (IHD): History of myocardial infarction or a positive exercise test, current chest pain considered to be ischemic, use of nitrate therapy, or ECG with pathological Q waves.\n3.  History of congestive heart failure (CHF): History of CHF, paroxysmal nocturnal dyspnea, orthopnea, bilateral rales, or S3 gallop.\n4.  History of cerebrovascular disease (CVA): History of transient ischemic attack or stroke.\n5.  Preoperative treatment with insulin.\n6.  Preoperative serum creatinine $> 2.0$ mg/dL.\n\nNext, we evaluate the patient's clinical data against each of these six criteria to compute the total RCRI score.\n\n1.  **High-risk surgery:** The patient is scheduled for an \"elective open sigmoid colectomy,\" which is specified as an \"intraperitoneal operation.\" This type of major abdominal surgery is classified as high-risk. Therefore, this criterion is met. This contributes $1$ point to the score.\n\n2.  **History of ischemic heart disease:** The problem explicitly states \"no known ischemic heart disease\" and the patient \"denies chest pain.\" Therefore, this criterion is not met. This contributes $0$ points.\n\n3.  **History of congestive heart failure:** The problem explicitly states \"no history of congestive heart failure\" and the patient \"denies... orthopnea.\" Therefore, this criterion is not met. This contributes $0$ points.\n\n4.  **History of cerebrovascular disease:** The problem states the patient has a \"prior ischemic cerebrovascular accident.\" Therefore, this criterion is met. This contributes $1$ point.\n\n5.  **Preoperative treatment with insulin:** The problem states the patient has \"type $2$ diabetes mellitus treated with basal-bolus insulin.\" The use of insulin for diabetes management meets this criterion, regardless of the type of diabetes. Therefore, this criterion is met. This contributes $1$ point.\n\n6.  **Preoperative serum creatinine $> 2.0$ mg/dL:** The problem states the patient has \"chronic kidney disease with a most recent preoperative serum creatinine of $2.1$ mg/dL.\" Since $2.1 > 2.0$, this criterion is met. This contributes $1$ point.\n\nThe total RCRI score is the sum of the points from each met criterion:\n$$ \\text{RCRI Score} = 1 (\\text{surgery type}) + 0 (\\text{IHD}) + 0 (\\text{CHF}) + 1 (\\text{CVA}) + 1 (\\text{insulin}) + 1 (\\text{creatinine}) = 4 $$\nThe patient has an RCRI score of $4$.\n\nThe next step is to map this score to the estimated probability of MACE (defined as myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block) according to the original risk categories published by Lee et al.\nThe risk categories are as follows:\n-   RCRI Score $0$: Risk of MACE is $0.4\\%$\n-   RCRI Score $1$: Risk of MACE is $0.9\\%$\n-   RCRI Score $2$: Risk of MACE is $6.6\\%$\n-   RCRI Score $\\geq 3$: Risk of MACE is $11\\%$\n\nThe patient's score of $4$ falls into the highest risk category (RCRI Score $\\geq 3$). Therefore, the estimated probability of a major adverse cardiac event is $11\\%$. Expressed as a pure decimal number, this is $0.11$. To round to three significant figures as requested, the value is $0.110$.\n\nFinally, we apply the standard decision framework from professional society guidelines (e.g., American College of Cardiology/American Heart Association) regarding further noninvasive cardiac testing. The guidelines recommend a stepwise approach.\n1.  Is the surgery emergent? No, it is elective.\n2.  Does the patient have active cardiac conditions? No, this is ruled out by history, examination, and ECG.\n3.  What is the surgical risk? It is a high-risk intraperitoneal procedure.\n4.  What is the patient's functional capacity? It is poor, stated as $<4$ metabolic equivalents (METs).\n5.  What is the patient's risk based on a clinical risk calculator? The RCRI score is $4$, which corresponds to a MACE risk of $11\\%$. This is considered an elevated risk (threshold is typically $>1\\%$).\n\nAccording to the algorithm, for a patient with poor functional capacity ($<4$ METs) and elevated clinical risk undergoing a high-risk elective surgery, one should consider the utility of further noninvasive cardiac testing (e.g., stress echocardiography, nuclear stress test). The crucial consideration is whether the results of such testing would change management. In contemporary practice, there is a strong consensus that the results are unlikely to change management. The patient has a clear indication for surgery (\"complicated diverticulitis\"). Major randomized trials have shown that preoperative coronary revascularization (e.g., stenting) in patients with stable coronary artery disease does not improve perioperative outcomes compared to optimal medical therapy alone. Therefore, even if a stress test were to reveal significant but stable ischemia, the most probable course of action would not be to subject the patient to coronary intervention before the necessary colectomy, but rather to proceed with the surgery while ensuring optimal medical management (e.g., continuation of any beta-blockers, statins, and tight glycemic control) and vigilant hemodynamic monitoring. Since the results of further testing would not alter the plan to proceed with medically optimized surgery, such testing is not warranted. The focus shifts from risk stratification to risk modification through medical management.",
            "answer": "$$ \\boxed{0.110} $$"
        },
        {
            "introduction": "Identifying risk is only the first step; optimizing the patient's condition is the ultimate goal of preoperative evaluation. Managing type 1 diabetes through the perioperative period is a high-stakes balancing act between preventing life-threatening diabetic ketoacidosis and avoiding dangerous hypoglycemia. This exercise  provides a hands-on opportunity to apply core physiological principles to construct a safe and effective insulin management plan, translating risk assessment into direct, patient-centered action.",
            "id": "4659786",
            "problem": "A patient with type 1 diabetes mellitus managed on a basal–bolus insulin regimen is scheduled as the first case for elective general surgery with preoperative fasting beginning at midnight. The home regimen is subcutaneous insulin glargine given once nightly as the basal component and subcutaneous rapid-acting insulin with meals as the bolus component. The patient has normal renal function, no recent episodes of severe hypoglycemia, and no acute intercurrent illness. The most recent nightly basal dose is $26$ units of insulin glargine. On the morning of surgery, a preoperative capillary blood glucose is measured at $198$ mg/dL, and the institutional target intraoperative blood glucose range is $140$ to $180$ mg/dL.\n\nStarting from fundamental physiologic and clinical principles applicable to perioperative care of patients with type 1 diabetes mellitus, derive a scientifically sound, preoperative and intraoperative insulin adjustment plan that maintains basal insulin to prevent ketogenesis, withholds prandial insulin while the patient is fasting, and specifies the approach to intraoperative glucose monitoring and correction. Your derivation must explicitly justify the fractional adjustment of the basal dose for the night before morning surgery in a fasting patient with type 1 diabetes mellitus and normal renal function, using widely accepted clinical rules to balance hypoglycemia risk with prevention of ketosis.\n\nAs a quantitative check on your derivation, compute the recommended adjusted insulin glargine dose for administration the night before surgery. Express the dose in units (U) and round your answer to three significant figures.",
            "solution": "The problem statement is evaluated as valid. It presents a clinically realistic scenario in preoperative patient management that is scientifically grounded, well-posed, and objective. It contains sufficient and consistent data to derive a management plan and perform the required calculation based on established physiological principles and evidence-based clinical guidelines.\n\nThe derivation of the insulin adjustment plan proceeds from the fundamental pathophysiology of type 1 diabetes mellitus (T1DM). Patients with T1DM have an absolute deficiency of endogenous insulin production. Insulin serves two primary roles: a prandial (bolus) role, which manages nutrient influx after meals, and a basal role, which provides a constant low level of insulin to suppress endogenous glucose production (gluconeogenesis and glycogenolysis) and, critically, to suppress lipolysis and subsequent ketogenesis. In the absence of basal insulin, a patient with T1DM will develop diabetic ketoacidosis (DKA), a life-threatening metabolic state, even in a fasting condition. This principle establishes that basal insulin must be continued through the perioperative period.\n\nThe patient is scheduled for elective surgery and will be fasting (nil per os, NPO) from midnight. The NPO status eliminates the need for prandial insulin, as there is no exogenous carbohydrate intake. Therefore, the bolus component of the patient's regimen—the rapid-acting insulin administered with meals—must be withheld on the morning of surgery to prevent severe hypoglycemia.\n\nThe core of the problem lies in adjusting the basal insulin dose. The patient's home basal insulin is insulin glargine, a long-acting analog, taken at a dose of $D_{home} = 26$ units nightly. This dose is calibrated for a typical day involving food intake and normal activity. The perioperative state introduces two competing factors:\n1.  **Fasting:** The absence of caloric intake reduces the overall insulin requirement and increases the risk of hypoglycemia if the full home dose is administered.\n2.  **Surgical Stress:** The physiological stress of surgery elevates counter-regulatory hormones (e.g., cortisol, catecholamines, glucagon), which antagonize the action of insulin and promote hyperglycemia.\n\nA sound management plan must balance the risk of hypoglycemia from insulin administration in a fasting state against the risk of hyperglycemia and DKA from insufficient insulin action, exacerbated by surgical stress. Complete cessation of basal insulin is contraindicated due to the high risk of DKA. Therefore, the standard of care is to administer a reduced dose of the long-acting basal insulin. For patients with T1DM on a long-acting insulin analog like glargine, with normal renal function and good glycemic control, a reduction of the usual dose by $20\\%$ to $25\\%$ the night before surgery is widely accepted. This fractional reduction provides sufficient insulin to suppress ketogenesis while mitigating the risk of overnight and morning hypoglycemia.\n\nWe will select a reduction of $20\\%$. The adjusted dose, $D_{adj}$, is calculated as:\n$$D_{adj} = D_{home} \\times (1.00 - 0.20) = D_{home} \\times 0.80$$\n\nOn the morning of surgery, the patient's capillary blood glucose is measured at $198$ mg/dL. This is\nabove the institutional target intraoperative range of $140$ to $180$ mg/dL. This mild hyperglycemia should be treated with a small correction dose of subcutaneous rapid-acting insulin preoperatively to bring the glucose level closer to the target range before induction of anesthesia. The size of this dose would be calculated based on the patient's insulin sensitivity factor.\n\nIntraoperatively, glucose levels must be monitored frequently, typically every $1$ to $2$ hours, to allow for timely intervention. The preferred method for maintaining glycemic control during general surgery is a variable-rate continuous intravenous insulin infusion. This method allows for precise, real-time titration of insulin delivery to maintain the blood glucose within the target range of $140-180$ mg/dL.\n\nTo summarize the derived plan:\n1.  **Night before surgery:** Administer a reduced dose of insulin glargine.\n2.  **Morning of surgery:** Withhold the prandial (rapid-acting) insulin. Measure blood glucose and administer a small correction dose of rapid-acting insulin for the measured hyperglycemia of $198$ mg/dL.\n3.  **Intraoperatively:** Initiate a continuous intravenous insulin infusion and monitor blood glucose frequently (e.g., every hour) to maintain levels within the target range of $140-180$ mg/dL.\n\nAs a quantitative check, we will now compute the recommended adjusted insulin glargine dose for the night before surgery.\nGiven the home basal dose $D_{home} = 26$ units.\nUsing the clinically established reduction of $20\\%$, the fraction of the dose to be administered is $80\\%$.\n$$D_{adj} = 26 \\text{ units} \\times 0.80$$\n$$D_{adj} = 20.8 \\text{ units}$$\nRounding to three significant figures as requested, the dose remains $20.8$ units.",
            "answer": "$$\n\\boxed{20.8}\n$$"
        }
    ]
}